Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-14T04:27:33.175Z Has data issue: false hasContentIssue false

Potential Uses of a National Healthcare-Associated Infection Reporting System

Published online by Cambridge University Press:  31 August 2016

Graham M. Snyder*
Affiliation:
Department of Health Care Quality, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts
Daniel J. Morgan
Affiliation:
VA Maryland Healthcare System and Department of Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, Maryland
*
Address correspondence to Graham Snyder, MD, 330 Brookline Ave, Mailstop SL-435, Boston, MA 02115 (gsnyder@bidmc.harvard.edu).

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Concise Communications
Copyright
© 2016 by The Society for Healthcare Epidemiology of America. This is a work of the U.S. Government and is not subject to copyright protection in the United States. All rights reserved. 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Edwards, JR, Peterson, KD, Andrus, ML, et al. National Healthcare Safety Network (NHSN) Report, data summary for 2006, issued June 2007. Am J Infect Control 2007;35:290301.Google Scholar
2. About |NHSN| CDC. Centers for Disease Control and Prevention website. http://www.cdc.gov/nhsn/about-nhsn/index.html. Published 2015. Accessed June 5, 2016.Google Scholar
3. Weiner, LM, Webb, AK, Walters, MS, et al. Policies for controlling multidrug-resistant organisms in US healthcare facilities reporting to the National Healthcare Safety Network, 2014. Infect Control Hosp Epidemiol 2016;37:11051108.CrossRefGoogle Scholar
4. Morgan, DJ, Murthy, R, Munoz-Price, LS, et al. Reconsidering contact precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2015;36:11631172.Google Scholar
5. Guidance for control of carbapenem-resistant Enterobacteriaceae (CRE) – November 2015 Update – CRE Toolkit. Centers for Disease Control and Prevention website. http://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf. Published 2015. Accessed June 5, 2016.Google Scholar
6. Patient Safety Component-Annual Hospital Survey. Centers for Disease Control and Prevention website. http://www.cdc.gov/nhsn/forms/57.103_pshospsurv_blank.pdf. Published 2015. Accessed June 5, 2016.Google Scholar
7. Schwaber, MJ, Lev, B, Israeli, A, et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52:848855.CrossRefGoogle Scholar
8. Palmore, TN, Henderson, DK. Managing transmission of carbapenem-resistant enterobacteriaceae in healthcare settings: a view from the trenches. Clin Infect Dis 2013;57:15931599.CrossRefGoogle ScholarPubMed
9. Datta, R, Brown, S, Nguyen, VQ, et al. Quantifying the exposure to antibiotic-resistant pathogens among patients discharged from a single hospital across all California healthcare facilities. Infect Control Hosp Epidemiol 2015;36:12751282.CrossRefGoogle ScholarPubMed
10. Safdar, N, Anderson, DJ, Braun, BI, et al. The evolving landscape of healthcare-associated infections: recent advances in prevention and a road map for research. Infect Control Hosp Epidemiol 2014;35:480493.CrossRefGoogle Scholar
11. TAP Strategy |HAI| CDC. Centers for Disease Control and Prevention website. www.cdc.gov/hai/prevent/tap.html. Published 2016. Accessed June 5, 2016.Google Scholar